Press release
Natural Killer (NK)-Cell Lymphoma Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | CytoVac, ImmunityBio, Innate Pharma, Dragonfly, Celularity, Deverra, Nkarta, XNK Therapeutics
"Natural Killer (NK)-Cell Lymphoma Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Natural Killer (NK)-Cell Lymphoma Therapeutics Market.
The report provides a detailed description of the Natural Killer (NK)-Cell Lymphoma drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Natural Killer (NK)-Cell Lymphoma Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/natural-killer-nk-cell-lymphoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Natural Killer (NK)-Cell Lymphoma Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Natural Killer (NK)-Cell Lymphoma therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Natural Killer (NK)-Cell Lymphoma treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Natural Killer (NK)-Cell Lymphoma drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Natural Killer (NK)-Cell Lymphoma treatment market.
Learn More about the Clinical and Commercial Development Activities in the Natural Killer (NK)-Cell Lymphoma Therapeutics Domain:
https://www.delveinsight.com/report-store/natural-killer-nk-cell-lymphoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Natural Killer (NK)-Cell Lymphoma Therapeutics Analysis
NK cell abnormalities have been observed in several cancer patients, including decreased cytotoxicity, defective expression of activating receptors or intracellular signaling molecules, overexpression of inhibitory receptors, defective proliferation, decreased numbers in peripheral blood and tumor infiltrate, and defective cytokine production.
Several research groups have developed protocols for in vitro NK cell differentiation based on reconstitution with cytokines, providing a good strategy for amplifying NK cells for therapeutic applications. The upcoming technologies and recent advances in understanding the manipulation of NK cell activation and development have led to the hope that NK cells could be harnessed as immunotherapy for cancers and other diseases.
There are approx. 100+ key companies that are developing therapies for Natural Killer Cell Therapies. Currently, Innate Pharma is leading the therapeutics market with its Natural Killer Cell Therapies drug candidates in the most advanced stage of clinical development.
Natural Killer (NK)-Cell Lymphoma Companies in the Therapeutics Market Include:
Abivax, Acepodia, Affimed Therapeutics AG, Allife Medical Science and Technology, Artiva Biotherapeutics, Asclepius Technology Company Group, Bellicum Pharmaceuticals, Bright Path Biotherapeutics, Bristol-Myers Squibb, Cantargia, Cellid Company, Chongqing Sidemu Biotechnology, CureTech, CytoVac, Dynavax, Five Prime Therapeutics, Glycostem Therapeutics (IPD Therapeutic), Green Cross Corporation, GT Biopharma, HiberCell, ImmunityBio, Innate Pharma, Kiadis Pharma, Kuur Therapeutics (Formerly Cell Medica), Multimmune GmbH, NantKwest, Nektar Therapeutics, NKMax, PersonGen BioTherapeutics (Suzhou), Synimmune, Wugen, XNK Therapeutics, and many others.
Emerging and Marketed Natural Killer (NK)-Cell Lymphoma Therapies Covered in the Report Include:
• ALECSAT: CytoVac
• ALT 803: ImmunityBio
• Monalizumab: Innate Pharma
• NKTR-214 (Bempegaldesleukin): Nektar Therapeutics
• PNK-007: Celularity
• DVX-201: Deverra Therapeutics
• NKX101: Nkarta Therapeutics
• CellProtect: XNK Therapeutics
• CYTO NK-102: CytoImmune Therapeutics
• CNTY-102: Century Therapeutics
• DF 1001: Dragonfly Therapeutics
And many more
Get an in-depth Assessment of the Emerging Therapies and Natural Killer (NK)-Cell Lymphoma Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Natural Killer (NK)-Cell Lymphoma Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Natural Killer Cell Therapies pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intracranial
• Intramuscular
• Intratumoral
• Intravenous
• Intravenous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types such as
• Small molecule
• Antibodies
• Beta Glucans
• CAR-NK cell therapy
• Cell Therapy
• Gene therapies
• Glycolipid
• NK Cell therapy
• NK T-Cell therapy
• Oligodeoxyribonucleotides
• Proteins
• RNA
• Stem cell therapies
• Vaccines
Request for Sample PDF to Understand More About the Natural Killer (NK)-Cell Lymphoma Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Natural Killer (NK)-Cell Lymphoma Current Treatment Patterns
4. Natural Killer (NK)-Cell Lymphoma - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Natural Killer (NK)-Cell Lymphoma Late-Stage Products (Phase-III)
7. Natural Killer (NK)-Cell Lymphoma Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Natural Killer (NK)-Cell Lymphoma Discontinued Products
13. Natural Killer (NK)-Cell Lymphoma Product Profiles
14. Natural Killer (NK)-Cell Lymphoma Companies
15. Natural Killer (NK)-Cell Lymphoma Drugs
16. Dormant and Discontinued Products
17. Natural Killer (NK)-Cell Lymphoma Unmet Needs
18. Natural Killer (NK)-Cell Lymphoma Future Perspectives
19. Natural Killer (NK)-Cell Lymphoma Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Natural Killer (NK)-Cell Lymphoma Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | CytoVac, ImmunityBio, Innate Pharma, Dragonfly, Celularity, Deverra, Nkarta, XNK Therapeutics here
News-ID: 3243943 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Cell
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
